Clinical Trial Update: β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients [NA]

View source ↗

Summary

This completed trial compared beta-D-glucan–guided surveillance with preemptive anidulafungin versus standard care in surgical ICU patients with invasive candid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Candidiasis

Drugs mentioned

• Anidulafungin (anidulafungin)

Snippet

Sponsor: Duke University | Conditions: Invasive Candidiasis | NA | Status: COMPLETED | Results posted: 2013-04-22